Search Results - "Maloni, H."

The Gulf War era multiple sclerosis cohort: 3. Early clinical features by Wallin, M. T., Culpepper, W. J., Maloni, H., Kurtzke, J. F.

“…Objectives To present clinical features at diagnosis for a large nationwide incident cohort of multiple sclerosis (MS) among those serving in the US military…”
Get full text

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS by CALABRESI, P. A, FIELDS, N. S, MCFARLAND, H. F, RACKE, M. K, MALONI, H. W, HANHAM, A, CARLINO, J, MOORE, J, LEVIN, M. C, DHIB-JALBUT, S, TRANQUILL, L. R, AUSTIN, H

“…Transforming growth factor (TGF)-beta2 is a pleiotropic cytokine associated with remissions in multiple sclerosis (MS) and amelioration of allergic…”
Get full text

VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta by CALABRESI, P. A, PELFREY, C. M, TRANQUILL, L. R, MALONI, H, MCFARLAND, H. F

“…Adhesion molecules are likely to play a critical role in the immunopathogenesis of multiple sclerosis (MS). The interaction of vascular cell adhesion…”
Get full text

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA by Soldan, Samantha S, Berti, Rossana, Salem, Nazi, Secchiero, Paola, Flamand, Louis, Calabresi, Peter A, Brennan, Meghan B, Maloni, Heidi W, Mcfarland, Henry F, Lin, Hun-Chi, Patnaik, Madhumita, Jacobson, Steven

“…Viruses have long been suggested to be involved in the etiology of multiple sclerosis (MS). This suggestion is based on (1) epidemiological evidence of…”
Get full text

Characterization of MRI response to treatment with interferon beta-1b : Contrast-enhancing MRI lesion frequency as a primary outcome measure by STONE, L. A, FRANK, J. A, ALBERT, P. S, BASH, C. N, CALABRESI, P. A, MALONI, H, MCFARLAND, H. F

“…MRI is a valuable tool to examine the pathophysiology and natural history of multiple sclerosis (MS), and several large multicenter trials have utilized MRI as…”
Get full text

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions by Smith, M E, Stone, L A, Albert, P S, Frank, J A, Martin, R, Armstrong, M, Maloni, H, McFarlin, D E, McFarland, H F

“…It is now well established that clinically stable patients with relapsing-remitting multiple sclerosis have ongoing disease activity when evaluated by serial…”
Get more information

Impaired renal function in progressive multiple sclerosis by CALABRESI, P. A, AUSTIN, H, RACKE, M. K, GOODMAN, A, CHOYKE, P, MALONI, H, MCFARLAND, H. F

“…The authors analyzed renal function in 25 patients with progressive MS. The mean glomerular filtration rate (GFR) was 92 mL/min/1.73 m(2), compared to the…”
Get full text

Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis : relationship to course, gender, and age by STONE, L. A, SMITH, M. E, ALBERT, P. S, BASH, C. N, MALONI, H, FRANK, J. A, MCFARLAND, H. F

“…MRI has provided insight into the pathophysiology and course of MS, particularly through the use of a paramagnetic contrast agent that allows visualization of…”
Get full text

Pain in multiple sclerosis: an overview of its nature and management by Maloni, H W

“…Pain is experienced by approximately two-thirds of all people with multiple sclerosis (MS) at some time during the course of their disease. Pain in MS occurs…”
Get full text

MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies by McFarland, H F, Stone, L A, Calabresi, P A, Maloni, H, Bash, C N, Frank, J A

“…The use of magnetic resonance imaging (MRI) in multiple sclerosis (MS) has increased in our understanding of the natural history of the disease course and has…”
Get more information

Risk Factors for Disease Progression in a Diverse Population-based Multiple Sclerosis Cohort by Wallin, M. T., Culpepper, W., Maloni, H., Kurtzke, J. F.

Get full text

ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: correlation with MRI lesions by Calabresi, P.A, Fields, N.S, Farnon, E.C, Frank, J.A, Bash, C.N, Kawanashi, T, Maloni, H, Jacobson, S, McFarland, H.F

“…The Th1-like cytokines, interleukin 2 (IL-2), interferon gamma (IFN- γ), and lymphotoxin alpha (LT- α) have been implicated in the immunopathogenesis of…”
Get full text

Certification of multiple sclerosis nurses: an international perspective by Uccelli, M Messmer, Fraser, C, Battaglia, M A, Maloni, H, Wollin, J

“…The Multiple Sclerosis Nursing International Certification Board was formed as a special initiative of the International Organization of Multiple Sclerosis…”
Get more information

Expression pattern of activation and adhesion molecules on peripheral blood CD4 + T-lymphocytes in relapsing-remitting multiple sclerosis patients: a serial analysis by Stüber, A., Martin, R., Stone, L.A., Maloni, H., Mcfarland, H.F.

“…We studied the expression of various cell surface molecules (CD25, CD28, CD29, CD45RO, CD56, LFA-1, VLA-4) on peripheral blood CD4 + T-cells in 6…”
Get full text

Clinical safety of serial monthly administrations of gadopentetate dimeglumine in patients with multiple sclerosis : Implications for natural history and early-phase treatment trials by TRESLEY, R. M, STONE, L. A, FIELDS, N, MALONI, H, MCFARLAND, H, FRANK, J. A

“…Serial contrast magnetic resonance imaging (MRI) has played an increasingly important role in understanding natural-history and early-treatment trials of…”
Get full text

Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials by Frank, J A, Bash, C, Stone, L, Petrella, J, Maloni, H, McFarland, H

Get more information

CXCR3+ Naive T Helper Cell Percentages Correlate with Neuropsychological Test Abnormalities in Patients with MS (P04.102) by Royal, W., Lee-Wilk, T., Wallin, M., Bever, C., Kane, R., Maloni, H., Finkelstein, J., Cha, E., McCarthy, M., Levin, M., Tyor, W., Culpepper, J., Mitchell, L., Zhan, M.

“…Abstract only…”
Get full text

The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis by Stone, L A, Frank, J A, Albert, P S, Bash, C, Smith, M E, Maloni, H, McFarland, H F

“…Magnetic resonance imaging (MRI) has been a valuable tool to understand the pathophysiology and natural history of multiple sclerosis (MS), and increasing…”
Get more information

Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b by Calabresi, P A, Tranquill, L R, Dambrosia, J M, Stone, L A, Maloni, H, Bash, C N, Frank, J A, McFarland, H F

“…Interferon beta-1b reduces clinical exacerbations and disease activity in multiple sclerosis as shown by magnetic resonance imaging, but the mechanism of…”
Get more information

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis by McFarland, H F, Frank, J A, Albert, P S, Smith, M E, Martin, R, Harris, J O, Patronas, N, Maloni, H, McFarlin, D E

“…The highly variable clinical course and the lack of a direct measurement of disease activity have made evaluation of experimental therapies in multiple…”
Get more information